Cerivastatin for lowering lipids

Background Cerivastatin was the most potent statin until it was withdrawn from the market due to a number of fatalities due to rhabdomyolysis, however, the dose‐related magnitude of effect of cerivastatin on blood lipids is not known. Objectives Primary objective To quantify the effects of various d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2020-01, Vol.2020 (1), p.CD012501
Hauptverfasser:	Adams, Stephen P, Tiellet, Nicholas, Alaeiilkhchi, Nima, Wright, James M
Format:	Artikel
Sprache:	eng
Schlagworte:	A. Cardiovascular Disease: Primary Prevention A.1 Drugs A.1.2 Lipid Lowering Child health Cholesterol, HDL Cholesterol, HDL - blood Cholesterol, LDL Cholesterol, LDL - blood Dose-Response Relationship, Drug Drugs Heart & circulation Heart disease prevention Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hydroxymethylglutaryl‐CoA Reductase Inhibitors Hyperlipidemias Hyperlipidemias - blood Hyperlipidemias - drug therapy Lipids Lipids - blood Medicine General & Introductory Medical Sciences Pharmacological Therapies Prevention Pyridines Pyridines - therapeutic use Randomized Controlled Trials as Topic Statins Treatment of essential Hypertension Treatment Outcome Triglycerides Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!